Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosaEllie Rashidghamat, John A. McGrath, Salma Ayis et al.|Journal of the American Academy of Dermatology|2019Cited by 115